Isracann to buy Canadian natural medicine firm of $4M

Mugglehead
By Nick LabaMar 28, 2022, 5:46 pm211 pts
Israeli cannabis producer Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) is set to buy a medical research firm in Canada with the goal of eventually selling tested products to European markets. In a statement Monday, Isracann says it’s entered a deal to acquire all shares of Praesidio…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Nebraska AG Sends Threat Letters To Retailers Over Alleged Sales Of Illegal THC Products 50

Maryland: Governor Issues Additional Round of Marijuana-Related Pardons 18

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.